NASDAQ · Medical - Devices

IRMD (IRMD) Stock

$95.08 +0.62% NASDAQ: IRMD Healthcare

Valuation

MetricValue
Price$95.08
Market Cap$1.22B
P/E Ratio46.31
P/B Ratio11.00
P/S Ratio12.56
EPS (TTM)$1.83
52-Week High$107.90
52-Week Low$55.11
Dividend Yield1.43%

Financials & Margins

MetricValue
ROE25.04%
ROA16.17%
ROCE27.37%
Gross Margin76.84%
Operating Margin32.40%
Net Margin27.36%
Debt/Equity0.00
Current Ratio8.10

Annual Financials (USD)

Metric20212022202320242025
Revenue$42.0M$53.0M$66.0M$73.0M$84.0M
Operating Profit$10.0M$16.0M$20.0M$22.0M$26.0M
Net Profit$9.0M$13.0M$17.0M$19.0M$22.0M
EPS$0.74$1.02$1.35$1.50$1.75
Op Margin23.5%29.3%30.6%30.0%31.2%

Balance Sheet (USD)

Metric20212022202320242025
Total Assets$83.0M$86.0M$92.0M$98.0M$109.0M
Total Liabilities$11.0M$12.0M$21.0M$12.0M$14.0M
Cash$62.0M$58.0M$50.0M$52.0M$51.0M
Borrowings$2.0M$2.0M$2.0M$0$0

Latest News

Iradimed Insider Sold Shares Worth $285,000, According to a Recent SEC Filing MT Newswires · Jun 4, 2026 Assessing IRADIMED (IRMD) Valuation After Strong Multi Year Returns And A Premium P/E Multiple Simply Wall St. · Jun 3, 2026 IRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving It Motley Fool · Jun 2, 2026 Iradimed Insider Sold Shares Worth $691,044, According to a Recent SEC Filing MT Newswires · May 28, 2026 Iradimed Corp (IRMD): 3 Things That Stood Out From Q1 Report Insider Monkey · May 27, 2026

Cash Flow (USD)

Metric20212022202320242025
Operating Cash Flow$11.0M$10.0M$13.0M$26.0M$25.0M
Investing Cash Flow$0$-3.0M$-16.0M$-17.0M$-16.0M
Financing Cash Flow$0$0$0$-1.0M$-3.0M
Net Cash Flow$12.0M$-4.0M$-8.0M$2.0M$-1.0M
Free Cash Flow$11.0M$8.0M$5.0M$18.0M$17.0M

Valuation & Return Ratios

MetricValue
PEG Ratio2.46
EV / EBITDA34.96
FCF Yield2.22%
Quick Ratio7.13
Interest Coverage—
Return 1Y66.96%
Return 3Y116.15%
Return 5Y199.20%

Peer Comparison

TickerPriceChangeP/EMarket CapDiv Yield
AHCO $11.17 -0.45% 8.52 $1.52B 0.00%
AXGN $40.48 +2.51% 60.40 $2.15B 0.00%
CRON $2.83 -2.08% -131.00 $1.06B 0.00%
CTEVClaritev Corporation $21.73 +0.56% -1.25 $370.45M 0.00%
GDRX $3.12 +2.30% 28.44 $1.08B 0.00%

About IRMD

IRMD is led by CEO Roger E. Susi, employs 160 people, headquartered in US, publicly traded since 2014.

IRMD stock trades at $95.08 with a market capitalization of $1.22B. The stock is valued at a price-to-earnings (P/E) ratio of 46.31, price-to-book of 11.00, price-to-sales of 12.56. Over the past 52 weeks the stock has ranged between $55.11 and $107.90, and currently trades 11.9% below its 52-week high. It pays a dividend yielding 1.43%.

On profitability, IRMD generates a return on equity (ROE) of 25.04% — well above the market average, a sign of a high-quality business, return on capital employed of 27.37%, an operating margin of 32.40%, a net profit margin of 27.36%.

Related Healthcare Stocks

LLY Drug Manufacturers - General $1185.71 -0.52% JNJ Drug Manufacturers - General $259.24 +0.88% ABBV Drug Manufacturers - General $246.04 +0.89% UNH Medical - Healthcare Plans $407.08 +0.77% MRK Drug Manufacturers - General $128.57 +0.16% NVS Drug Manufacturers - General $158.83 -0.64% NVO Biotechnology $51.58 +1.22% TMO Medical - Diagnostics & Research $594.00 +2.41% AMGN Drug Manufacturers - General $387.64 -1.39% ABT Medical - Devices $108.03 +0.70% GILD Drug Manufacturers - General $132.73 -1.18% PFE Drug Manufacturers - General $26.74 +2.06%

Popular Stocks

Apple (AAPL)Microsoft (MSFT)NVIDIA (NVDA)Alphabet (GOOGL)Amazon (AMZN)Meta (META)Tesla (TSLA)Broadcom (AVGO)JPMorgan (JPM)Visa (V)

Screens featuring this stock

High ROE Healthcare StocksLow P/E Healthcare StocksHigh Net Margin Healthcare StocksDividend Healthcare StocksLow Debt Healthcare StocksNasdaq High ROE StocksAll stock screens
Run Stock Screener Investing Guides